Through harnessing innovations in its regulatory processes, including digital transformation in health care, BPOM is ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Unauthorised purchase of medicines and equipment from a private agency has come under the scanner of Central Bureau of Investigation (CBI) which is probing the financial irregularities in R.G. Kar ...

The Consumer Healthcare Products Association, which represents manufacturers and marketers of over-the-counter medicines, ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...

"Generic drugs are used around the world. There are no doubts about their safety and efficacy as they have undergone ...